Steroid Treatment for Severe Alcoholic Hepatitis
Prednisolone 40 mg daily for 28 days is the recommended first-line treatment for severe alcoholic hepatitis, defined as having a Maddrey Discriminant Function (mDF) score ≥32 or hepatic encephalopathy. 1
Diagnosis and Assessment
Severe alcoholic hepatitis requiring steroid treatment is defined by:
Patients with mild alcoholic hepatitis (mDF <32, MELD <18, GAHS <8) generally improve with abstinence and supportive care alone 1
First-Line Treatment
Prednisolone 40 mg daily for 28 days is the standard treatment regimen for severe alcoholic hepatitis 1
Methylprednisolone 32 mg daily is an acceptable alternative to prednisolone 1, 2
Steroid therapy has been shown to improve short-term (28-day) survival in patients with severe alcoholic hepatitis 1, 2
Contraindications to Steroid Therapy
- Steroids are contraindicated in patients with: 1
- Active infection or sepsis
- Gastrointestinal bleeding
- Acute renal failure
- Acute pancreatitis
Monitoring Response to Treatment
Early response to steroid treatment should be assessed at day 7 using: 1
- Early Change in Bilirubin Level (ECBL): Bilirubin level at day 7 should be lower than day 1
- Lille model score: Categorizes patients as:
- Complete responders (score ≤0.16)
- Partial responders (score 0.16-0.56)
- Null responders (score ≥0.56)
28-day survival rates based on Lille score: 1
- Complete responders: 91.1%
- Partial responders: 79.4%
- Null responders: 53.3%
Treatment Algorithm
For patients with mDF ≥32 without contraindications:
If Lille score <0.56 (responder):
If Lille score ≥0.56 (null responder):
For patients with contraindications to steroids:
Alternative Treatments
Pentoxifylline:
Combination therapy:
N-acetylcysteine with corticosteroids:
Common Pitfalls and Caveats
Steroid therapy should not be delayed excessively; however, a systematic evaluation taking up to a week before initiation is reasonable to rule out contraindications 3
Infections are a common complication of steroid therapy, occurring in 13% of treated patients versus 7% in untreated patients 4, 3
Long-term outcomes depend primarily on achieving alcohol abstinence, which should be strongly recommended to all patients 1
The 6-month survival rate is 82% in patients with confirmed ECBL but only 23% in those without ECBL 1
Despite improving short-term survival, steroids have not consistently shown benefits in medium or long-term survival 1, 4